A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-19981-6

PubMed Identifier: 33323937

Publication URI: http://europepmc.org/abstract/MED/33323937

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723